Fengze Sun

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Heat Shock Protein

Top Venues

Molecular cancer therapeutics

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Nan Fang, Bing Liu, Qiu-Zhong Pan, Tingting Gong, Meixiao Zhan, Jingjing Zhao, Qi-Jing Wang, Yan Tang, Yong-Qiang Li, Jia He, Tong Xiang, Fengze Sun, Li-Gong Lu, Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular cancer therapeutics 23 (8) (2024)
Nan Fang, Bing Liu, Qiu-Zhong Pan, Tingting Gong, Meixiao Zhan, Jingjing Zhao, Qi-Jing Wang, Yan Tang, Yong-Qiang Li, Jia He, Tong Xiang, Fengze Sun, Li-Gong Lu, Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity. Molecular cancer therapeutics (2024)
Fengze Sun, Yuanyuan Liu, Tingting Gong, Qiuzhong Pan, Tong Xiang, Jingjing Zhao, Yan Tang, Hao Chen, Yulong Han, Mengjia Song, Yue Huang, Han Li, Yuanyuan Chen, Chaopin Yang, Jieying Yang, Qijing Wang, Yongqiang Li, Jia He, Desheng Weng, Ruiqing Peng, Jian-Chuan Xia
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin. Cell death & disease 12 (12) (2021)